Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)

BACKGROUND: Psoriasis imposes a significant treatment burden on patients, particularly impacting well-being and quality of life (QoL). The psychosocial impact of psoriasis treatments remains unexplored in most patient populations. OBJECTIVE: To assess the impact of adalimumab on health-related QoL (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong Hyun, Son, Sang Wook, Jeong, Ki-Heon, Ahn, Jiyoung, Lee, Eun-So, Kim, Il-Hwan, Lee, Un Ha, Park, Hai-Jin, Ko, Joo Yeon, Kim, Byung-Soo, Kim, Jin Ju, Rashid, Javed, Kim, Kwang Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112372/
https://www.ncbi.nlm.nih.gov/pubmed/37041704
http://dx.doi.org/10.5021/ad.22.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112372/
https://www.ncbi.nlm.nih.gov/pubmed/37041704
http://dx.doi.org/10.5021/ad.22.041

Ejemplares similares